KD Logo

Insider Selling: Del Carmen Jeffrey, Catalyst Pharmaceuticals Inc [CPRX] Chief Commercial Officer divested 7,541 shares

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Catalyst Pharmaceuticals Inc shares valued at $121,184 were sold by Del Carmen Jeffrey on Jun 07 ’24. At $16.07 per share, Del Carmen Jeffrey sold 7,541 shares. The insider’s holdings dropped to 18,427 shares worth approximately $0.28 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Also, INGENITO GARY sold 80,000 shares, netting a total of over 1,292,800 in proceeds. Following the sale of shares at $16.16 each, the insider now holds 51,391 shares.

Before that, Daly Richard J had sold 17,323 shares from its account. In a trade valued at $276,735, the President and CEO traded Catalyst Pharmaceuticals Inc shares for $15.97 each. Upon closing the transaction, the insider’s holdings decreased to 17,323 shares, worth approximately $3.56 million.

As published in their initiating research note from Citigroup on March 14, 2024, Catalyst Pharmaceuticals Inc [CPRX] has been a Buy and the price target has been revised to $27. Analysts at BofA Securities started covering the stock with ‘”a Buy”‘ outlook in a report released in early March. As of December 21, 2023, Oppenheimer has initiated its “an Outperform” rating for CPRX. Earlier on August 24, 2022, ROTH Capital downgraded its rating. Their new recommendation was “a Neutral” for CPRX stock which previously was a “a Buy”.

Analyzing CPRX Stock Performance

During the last five days, there has been a drop of approximately -1.75%. Over the course of the year, Catalyst Pharmaceuticals Inc shares have dropped approximately -9.70%. Shares of the company reached a 52-week high of $17.50 on 03/01/24 and a 52-week low of $13.12 on 02/08/24. A 50-day SMA is recorded $15.62, while a 200-day SMA reached $14.53. Nevertheless, trading volume fell to 1.18 million shares from 0.85 million shares the previous day.

Support And Resistance Levels for Catalyst Pharmaceuticals Inc (CPRX)

According to the 24-hour chart, there is a support level at 14.87, which, if violated, would cause prices to drop to 14.56. In the upper region, resistance lies at 15.38. The next price resistance is at 15.57. RSI (Relative Strength Index) is 41.99 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.54, which suggests the price will decrease in the coming days. Percent R is at 75.36%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Most Popular